Trials / Completed
CompletedNCT01225809
AD01 Follow up Extension Visit
Observational Follow-up Extension Study-visit to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD01 Applied During AFFiRiS001 in Patients With Alzheimer's Disease
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 17 (actual)
- Sponsor
- Affiris AG · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Patients who were vaccinated with AFFITOPE AD01 during AFFiRiS001 will undergo a long-term follow-up period to get more information regarding the safety profile of AFFITOPE AD01.
Conditions
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2010-12-01
- Completion
- 2011-01-01
- First posted
- 2010-10-21
- Last updated
- 2011-01-26
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01225809. Inclusion in this directory is not an endorsement.